Consistent with these results, an elevation of SphK1 can be observed in livers from humans with NAFLD, indicating the clinical significance of the SphK1–S1P axis in the development and progression of the disease [64]. Here, SPHK1 is linked to metabolic dysfunction-associated steatotic liver disease.